Bharat Immunologicals (India) Financial Ratios

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 22.20  0.95  4.47%

Use fundamental data analysis to double-check all available reported financial drivers of Bharat Immunologicals to find out if markets are presently mispricing the company. We found twenty-two available fundamental indicators for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Gross Profit, Debt to Equity and the relationship between Price to Book and Cash and Equivalents . Use Bharat Immunologicals to enhance returns of your portfolios. The stock experiences very speculative upward sentiment.. Check odds of Bharat Immunologicals to be traded at 27.75 in 30 days

Bharat Immunologicals Company Summary

Bharat Immunologicals competes with Tata Consultancy, Reliance Industries, Tata Consultancy, HDFC Bank, and HDFC BANK. Bharat Immunologicals Biologicals Corp Ltd offers oral polio vaccines diarrhea management kits for the management of diarrhea in young children zinc dispersible tablets and iron folic acid tablets for the treatment of iron deficiency and iron deficiency anemia. Bharat Immunologicals and Biologicals Corporationration Limited was founded in 1989 and is based in Bulandshahr India.

Bharat Immunologicals Cash and Equivalents vs Price to Earning

Bharat Immunologicals Biologicals Corp Ltd is rated below average in cash and equivalents category among related companies. It is rated below average in price to earning category among related companies .

Bharat Immunologicals Fundamentals

    
 Better Than Average     
    
 Worse Than Average Compare Bharat Immunologicals to competition
FundamentalsBharat ImmunologicalsPeer Average
Return On Asset(1.69) % (15.64) %
Profit Margin(4.18) % (5.50) %
Operating Margin(5.13) % (10.91) %
Current Valuation862.5 M152.14 B
Shares Outstanding43.18 M1.43 B
Price to Earning(17.70) times40.69 times
Price to Book2.50 times14.44 times
Price to Sales0.66 times17.81 times
Revenue1.28 B9.85 B
Gross Profit119 M21.75 B
EBITDA(56.51 M)1.41 B
Net Income(53.46 M)517.71 M
Cash and Equivalents152.27 M3.89 B
Cash per Share3.55 times5.17 times
Total Debt177.56 M7.36 B
Debt to Equity0.50 times0.72 times
Current Ratio1.69 times3.30 times
Earnings Per Share(1.24) times2.30 times
Number of Employees510.67 K
Market Capitalization947.8 M29.78 B
Z Score3.0708.73
< 28% 

Chance of Financial Distress

Bharat Immunologicals Biologicals Corp Ltd has less than 28 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Details

Compare

Compare Bharat Immunologicals To Peers
U Singh  CFO
CFO

Opportunity Range

September 24, 2017 Opportunity Range